Oyen WJ - Search Results

1

Clinical application of FDG-PET/CT in metastatic infections.

Kouijzer IJ, Vos FJ, Bleeker-Rovers CP, Oyen WJ. Kouijzer IJ, et al. Among authors: oyen wj. Q J Nucl Med Mol Imaging. 2017 Jun;61(2):232-246. doi: 10.23736/S1824-4785.16.02735-7. Epub 2016 Feb 16. Q J Nucl Med Mol Imaging. 2017. PMID: 26883515 Review.

2

Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.

Dams ET, Oyen WJ, Boerman OC, Claessens RA, Wymenga AB, van der Meer JW, Corstens FH. Dams ET, et al. Among authors: oyen wj. J Nucl Med. 1998 Jan;39(1):119-24. J Nucl Med. 1998. PMID: 9443750 Free article.

3

Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.

van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van der Meer JW, Corstens FH. van der Laken CJ, et al. Among authors: oyen wj. Eur J Nucl Med. 1998 May;25(5):535-46. doi: 10.1007/s002590050255. Eur J Nucl Med. 1998. PMID: 9575251 Review.

4

Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats.

Dams ET, Becker MJ, Oyen WJ, Boerman OC, Storm G, Laverman P, de Marie S, van der Meer JW, Bakker-Woudenberg IA, Corstens FH. Dams ET, et al. Among authors: oyen wj. J Nucl Med. 1999 Dec;40(12):2066-72. J Nucl Med. 1999. PMID: 10616887 Free article.

5

Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8.

Rennen HJ, Boerman OC, Oyen WJ, van der Meer JW, Corstens FH. Rennen HJ, et al. Among authors: oyen wj. J Nucl Med. 2001 Jan;42(1):117-23. J Nucl Med. 2001. PMID: 11197959 Free article.

6

New concepts in infection/inflammation imaging.

Rennen HJ, Corstens FH, Oyen WJ, Boerman OC. Rennen HJ, et al. Among authors: oyen wj. Q J Nucl Med. 2001 Jun;45(2):167-73. Q J Nucl Med. 2001. PMID: 11476166 Review.

7

Radiopharmaceuticals to image infection and inflammation.

Boerman OC, Rennen H, Oyen WJ, Corstens FH. Boerman OC, et al. Among authors: oyen wj. Semin Nucl Med. 2001 Oct;31(4):286-95. doi: 10.1053/snuc.2001.26189. Semin Nucl Med. 2001. PMID: 11710771 Review.

8

Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.

Drenth JP, Nagengast FM, Oyen WJ. Drenth JP, et al. Among authors: oyen wj. Eur J Nucl Med. 2001 Dec;28(12):1766-9. doi: 10.1007/s002590100645. Epub 2001 Oct 19. Eur J Nucl Med. 2001. PMID: 11734913

9

131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.

Brouwers AH, Dorr U, Lang O, Boerman OC, Oyen WJ, Steffens MG, Oosterwijk E, Mergenthaler HG, Bihl H, Corstens FH. Brouwers AH, et al. Among authors: oyen wj. Nucl Med Commun. 2002 Mar;23(3):229-36. doi: 10.1097/00006231-200203000-00005. Nucl Med Commun. 2002. PMID: 11891480 Clinical Trial.

10

Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.

Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, Ruers TJ. Langenhoff BS, et al. Among authors: oyen wj. J Clin Oncol. 2002 Nov 15;20(22):4453-8. doi: 10.1200/JCO.2002.12.134. J Clin Oncol. 2002. PMID: 12431968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

686 results

Search Page